The influence of adrenergic and cholinergic blocking drugs on the glycogen content of the brain in rats deprived of paradoxical sleep

Recent studies have pointed out biochemical and pharmacological phenomena associated with the mechanism or mechanisms of sleep, especially in its paradoxical phase (Jouvet, 1964; Mandel, 1964). Our previous experiments have shown that paradoxical sleep (PS) deprivation leads to the fall of total glycogen content in certain regions of the brains of cats (Mr?ulja, Raki? and Radulova?ki, 1967; Mr?ulja and Raki?, 1968) and rats (Karad?i? and Mr?ulja, 1969). It was shown that changes of glycogen content correspond to PS deprivation and that PS deprivation is a specific stress to which the CNS responds selectively. Alterations in the glycogen concentration in a number of different brain structures lead us to conclude that neural areas affected by PS deprivation are widely distributed. Jouvet (1962) was one of the first to suggest that a neurohumoral mechanism may be concerned in the control of and characteristics of sleep. Experiments have shown that both cholinergic and adrenergic mechanisms may be involved in the initiation, maintenance and control of sleep. It has also been pointed out that paradoxical sleep can be started and maintained by cholinergic drugs (Matsuzaki, Okada and Shuto, 1967, 1968), blocked or reduced by anticholinergic compounds (Matsuzaki et al., 1968), and stimulated by noradrenaline or by its precursor, DOPA (Matsumoto and Jouvet, 1964). Bowers, Hartmann and Freedman (1966) showed that the ACh level of the rat telencephalon decreases with PS deprivation while the levels of norpinephrine and serotonin remain the same (Barchas and Freedman, 1963). More recently, Pujol, Mouret, Jouvet and Glowinski (1968) found the increased turnover of cerebral norepinephrine during rebound of PS in the rat. It is also of interest to point out that probably both adrenergic and cholinergic processes participate in the glycogenolytic effect of physostigmine (Mr?ulja, Terzi? and Varagi?, 1968). It was suggested that physostigmine initiates the cholinergic processes which then trigger off adrenergic processes. The aim in the present work was to determine the glycogen content in certain brain regions of rats which were subjected to PS deprivation lasting 72 hr and treated with some cholinergic or beta-adrenergic blocking agents, as well as with a catecholamine depleting drug.     

Effect of adrenergic drugs on morphine-induced hyperglycemia.

Morphine hyperglycemia in the rabbit was blocked by hydergine but not by propranolol. Two monoamine oxidase inhibitors -- iproniazid and nialamide -- were also shown to prevent the hyperglycemia, but this effect could not be demonstrated with tranylcypromine.     

Studies on the hyperglycemia and hepatic glycogenolysis produced by alpha and beta adrenergic agonists in the cat

Previous studies in this laboratory showed that both alpha and beta receptors can mediate adrenergically-induced hyperglycemia in the cat. In the present study, the results of experiments on the isolated perfused cat liver provide affirmation that hepatic glycogenolysis in this species can be subserved by both types of receptors. Thus, the acute hepatic release of glucose induced by isoproterenol was found to be antagonized by propranolol but not by phentolamine or phenoxybenzamine. The opposite was found for the glycogenolytic action of phenylephrine. Experiments $\text{in}$$\text{vivo}$ showed that the hyperglycemic response to the beta agonist was associated with activation of hepatic phosphorylase and increased intracellular cAMP content while the hyperglycemia induced by the alpha agonist was associated with an activation of phosphorylase which was independent of cAMP.     

Cerebral glucose and glycogen metabolism in diazinon-treated animals

The intraperitoneal (IP) treatment of rats with diazinon (40 mg/kg) resulted in a variety of changes in the brain. Glycogen was depleted, but there was an increase in the activities of glycogen phosphorylase, phosphoglucomutase, hexokinase, lactate dehydrogenase, and fructose 1,6 diphosphatase. The activity of glucose-6-phosphatase was unaffected while that of cholinesterase was significantly reduced. Lactic acid content was increased, while that of pyruvate was not altered. Animals developed tremors and convulsions, which were maximal two hours after treatment. The induced changes may be compensatory mechanisms to provide extra energy to cerebral tissue as a result of the stimulatory effects in diazinon-treated animals.     

Tracheal gland mucous cells stimulated in vitro with adrenergic and cholinergic drugs

To determine the responsiveness of tracheal mucous cells to adrenergic and cholinergic stimulation, we analyzed changes in their structure induced by neurotransmitter-like agonists. Ferret tracheal rings were exposed for 30 min in vitro to one of the following: phenylephrine, isoproterenol, or bethanechol (all at 10(-5) M), in the presence of absence of appropriate antagonists. Electron microscopy and morphometric analysis revealed that the volume density of mucous cells (Vvmc, i.e. the space occupied by mucous cells in the submucosa) significantly decreased, and the surface density of mucous cell apical membrane (Svam) increased in response to isoproterenol and bethanechol but not to phenylephrine. In metabolic labeling experiments, the morphological changes were accompanied by secretagogue-evoked release of 35S-labeled macromolecules. Taken together, these data suggest that tracheal mucous cells secrete 35S-labeled macromolecules in response to beta-adrenergic and muscarinic agonists by an exocytotic process that involves a reduction in cell size.     

Effects of nootropic drugs on brain cholinergic and dopaminergic transmission

High affinity choline uptake (HACU) in the hippocampus and striatal concentration of dopamine (DA) and homovanillic acid (HVA) as measures of the in vivo acetylcholine and DA turnover, respectively, were estimated in male rats, Long-Evans, following 6-day administration of various nootropics in clinically relevant doses: piracetam and its derivatives pramiracetam and oxiracetam (100 mg/kg/day), pyritinol (50 mg/kg/day). Piracetam treatment was without effect on HACU, but induced significant increase of HVA in the striatum leaving striatal DA concentration unchanged. On the contrary, pyritinol, pramiracetam and oxiracetam increased HACU, but did not change striatal DA and HVA levels.     

Influence of cholinergic and adrenergic agents of the electric activity of the brain and the heart under hypoxia

Injection of adrenergic and cholinergic agents to animals in the normal athmospheric conditions did not tigger drastic changes on the electric activity of the brain and heart. Acutehipoxia demands high adaptability from the body. In such conditions stimulation of reticular formation and hypothalamus produces different changes in the EEG and ECG activity whith injecting adrenergic and cholinergic agents. It was determined that cholinergic influence are effective in the regulation of electrical brain activity while adrenergics are more important for the realization of descending influences of the truncus cerebri vegetative centers and are less active in the modulation of the cerebral cortex activity.     

Influence of adrenergic neuron blocking agents on the adrenaline-induced platelet reactions

Adrenaline causes aggregation of human blood platelets through stimulation of alpha-adrenoceptors resembling the alpha 2-type. Alpha-adrenoceptor blocking agents inhibit specifically the adrenaline-induced platelet reactions. The adrenaline-induced aggregation of human blood platelets was inhibited specifically by adrenergic neuron blocking agents such as guanoxan, guanclofine and guanethidine. Guanoxan (I50 = 0.6 mu mol/l) was about three orders of magnitude more effective than guanethidine, guanclofine occupied a median position. The compounds tested inhibited the ADP- and collagen-induced aggregation at relatively high concentrations. This is probably due to non-specific membrane effects. The known alpha-adrenolytic effect of guanoxan is believed to be mediated mainly by alpha 2-adrenoceptors.     

Effect of adrenergic blocking drugs on secretion of luteinizing hormone in the ovariectomized ewe.

The effects of the adrenergic blocking drugs phenoxybenzamine, phentolamine, and pimozide on basal luteinizing hormone (LH) levels and on estrogen-induced LH release were tested in ovariectomized ewes. Phentolamine was given at a dose of 10 mg/kg; phenoxybenzamine was given at a dose of 8 mg/kg; and pimozide was given at a dose of 800 mcg/kg. Estradiol benzoate (EB) was given at a dose of 50 mcg/animal. Sera were assayed for LH levels by double-antibody radioimmunoassay. Phenoxybenzamine given as a single dose significantly reduced basal LH levels. Given at extremenly high doses, phenoxybenzamine was unable to consistently block estrogen-induced LH release. Pimozide significantly reduced basal LH levels in the ewes and blocked or greatly reduced estrogen-induced LH release in 9 of 10 treated animals. Reduced basal LH levels were seen with phentolamine injection but were of short duration of action. It is concluded that normal function of noradrenergic neurons is required for maintenance of normal basal LH release but unnecessary for estrogen-induced LH release. Dopaminergic neurons appear to facilitate basal and estrogen-induced LH release.     

Effects of adrenergic and cholinergic drugs on electrical and mechanical activities of the rat cauda epididymidis in vitro

Electrical and mechanical activities of the rat epididymis (at 29 +/- 1.1 cm from the junction of the vas deferens) were recorded in vitro. The frequency of the spontaneous activity was 2.7 +/- 0.15/min. Adrenaline, phenylephrine, isoprenaline and carbachol increased the basal tension, frequency and amplitude of the contractions. Phentolamine, an alpha-adrenergic blocking agent, abolished the stimulatory effects of adrenaline and isoprenaline, but not those of carbachol. Propranolol and metoprolol, beta-adrenergic blocking agents, did not inhibit the stimulatory effects of isoprenaline. Atropine abolished the response to carbachol. The results suggest that alpha-adrenergic receptors but not beta-receptors are present in the rat epididymis.     

Effects of cholinergic and adrenergic drugs on intraluminal pressures and contractility of the rat testis and epididymis in vivo

Intravenous administration of methacholine (200 micrograms/kg) caused no changes in the seminiferous tubules of rats, but significantly increased intraluminal pressures and contractility of the caput, the corpus and the cauda epididymidis. The effect of methacholine was abolished by pretreatment with atropine (500 micrograms/kg), but not by phentolamine (400 micrograms/kg) or propranolol (400 micrograms/kg). Adrenaline (5-40 micrograms/kg), noradrenaline (5-40 micrograms/kg) and phenylephrine (100-400 micrograms/kg) had no effect on the seminiferous tubules, but dose-dependently elevated intraluminal pressures and enhanced the contractility of all regions of the epididymis. Isoproterenol (100-800 micrograms/kg) did not affect intraluminal pressures of the seminiferous tubules and the epididymal duct. The stimulatory effect of adrenergic agonists was specifically blocked by phentolamine, but not by propranolol or atropine. Cholinergic and adrenergic antagonists did not alter spontaneous contraction of the epididymis. The results suggest that the contractility of all segments of the rat epididymis, but not the seminiferous tubules, can be increased by autonomic drugs. The enhancing effect of adrenergic drugs is probably the result of activation through alpha-adrenergic receptors.     

Localization and release of lysozyme from ferret trachea: Effects of adrenergic and cholinergic drugs

Summary Lysozyme is a bacteriolytic enzyme found in respiratory tract fluid. In this study, immunocytochemistry was used to determine the cells of origin of tracheal lysozyme in the ferret. Lysozyme was found in secretory granules of serous but not mucous cells in the submucosal glands, and was absent from the surface epithelium, cartilage, and connective tissue. The exclusive presence of lysozyme in serous gland cells renders it useful as a biochemical marker of that cell type.Measurements of lysozyme assayed from the incubating medium indicated that bethanechol stimulated lysozyme release by 260±80.9% (mean ±SE), phenylephrine by 80±16.4%, and terbutaline by 25±10.2%. Electron-microscopic and immunocytochemical analysis of incubated tissues revealed loss of serous granules and lysozyme immuno-reactivity in response to the drugs. Atropine, propranolol, and phentolamine blocked the stimulatory effects of bethanechol, terbutaline, and phenylephrine, respectively.These findings establish the usefulness of lysozyme as a serous-cell marker and demonstrate that secretory responses of different magnitude are evoked by equimolar concentrations of alpha- and beta-adrenergic and cholinergic drugs.     

Comparative study of the cholinergic and adrenergic innervation of the cerebral vessels in humans and various laboratory animals

Choline- and adrenergic innervation of intracerebral branches of the middle and posterior cerebral arteries has been investigated histochemically and electron microscopically in slices, or after their preparation after W. Penfield. The vessels have been studied in the area of the fields 41, 17 of the cerebrum, trunk and spinal cord of the human being, cat and dog. When studying innervation of the intracerebral arteries (ICA), the preparation method has some advantages in comparison with investigation of these vessels in slices of the brain. Around most of the ICA from 200 up to 30 mcm in the diameter choline- and adrenergic nervous conductors are revealed. Using the method for calculating varicosities in nervous plexuses, it is demonstrated that degree of the ICA innervation is two times less than that in the arteries of similar caliber in the cerebral pia mater.     

The effects of some porphyrinogenic drugs on the brain cholinergic system.

In central nervous system, acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) hydrolyse acetylcholine. Diminished cholinesterase activity is known to alter several mental and psychomotor functions. The symptoms of cholinergic crisis and those observed during acute attacks of acute intermittent porphyria are very similar. The aim of this study was to investigate if there could be a link between the action of some porphyrinogenic drugs on brain and the alteration of the cholinergic system. To this end, AChE and BuChE activities were assayed in whole and different brain areas. Muscarinic acetylcholine receptor (mAChR) levels were also measured. Results obtained indicate that the porphyrinogenic drugs tested affect central cholinergic transmission. Quantification of mAChR gave quite different levels depending on the xenobiotic. Veronal administration inhibited 50% BuChE activity in whole brain, cortex and hippocampus; concomitantly cortex mAChR was 30% reduced. Acute and chronic isoflurane anaesthesia diminished BuChE activity by 70-90% in whole brain instead cerebellum and hippocampus mAChR levels were only altered by chronic enflurane anaesthesia. Differential inhibition of cholinesterases in the brain regions and their consequent effects may be of importance to the knowledge of the mechanisms of neurotoxicity of porphyrinogenic drugs.